|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses: | |
| Research and development | |
| Sales and marketing | |
| General and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Other income: | |
| Other income, net | |
| Net loss before income taxes | |
| Provision for (benefit from) income taxes | |
| Net loss | |
| Adjustment to reflect deemed contribution from Series D and Series E redeemable convertible preferred stock extinguishment | |
| Net loss attributable to common stockholders | |
| Net income (loss) per share attributable to common stockholders, basic (in usd per share) | |
| Net income (loss) per share attributable to common stockholders, diluted (in usd per share) | |
| Weighted average shares attributable to common stockholders, basic (in shares) | |
| Weighted average shares attributable to common stockholders, diluted (in shares) | |
| Other comprehensive loss: | |
| Unrealized gain (loss) on marketable securities, net of taxes | |
| Comprehensive loss |
Loading...
